Loading clinical trials...
Loading clinical trials...
Lung Transplant in Tandem With Bone Marrow Transplant for Combined Lung and Bone Marrow Failure
Conditions
Interventions
CD3/CD19 negative hematopoietic stem cells
Rituximab
+5 more
Locations
2
United States
UPMC Presbyterian
Pittsburgh, Pennsylvania, United States
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States
Start Date
April 19, 2018
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2028
Last Updated
January 13, 2026
NCT06238622
NCT07299695
NCT07466420
NCT06241560
NCT07407543
NCT07284459
Lead Sponsor
Paul Szabolcs
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions